Ovarian Cancer Trial, Recruiting NCT04751435 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT04751435
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Phase 1:

  • People aged 18 or older (based on self-report)
  • People who currently have, or have previously had, breast, ovarian, pancreatic, or prostate cancer (based on self-report)
  • People who identify as Black, Latino, or neither Black nor Latino
  • People who speak and read English, Haitian Creole, or Spanish at a "well" or "very well" level

Phase 2:

  • People aged 18 or older (confirmed through medical records)
  • People who currently have, or have previously had, breast, colorectal, ovarian, pancreatic, or prostate cancer that meets specific medical criteria for their cancer type, including factors such as age at diagnosis, cancer subtype, family history of certain cancers, or a doctor's referral (confirm specific criteria with trial site)
  • People who speak English, Haitian Creole, or Spanish at a "well" or "very well" level
  • People who have not previously received genetic counselling or genetic testing related to cancer risk

Who may not be able to join:

Phase 1 and Phase 2:

  • People whose ability to make their own decisions is considered impaired, as judged by a doctor or qualified consent professional
  • People whose fluency in English, Haitian Creole, or Spanish is rated as "not at all" or "not well"

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jada Hamilton, PhD, MPH, Memorial Sloan Kettering Cancer Center

Phone: 646-888-0049

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 November 2021
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of patients who complete the cognitive interview (Phase I); Genetic test decision (Phase II) satisfaction; Genetic counseling satisfaction (Phase II)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov